IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc.Β (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that...
50% of patients who received repeated doses (n=10) remained alive and in remission beyond the expected median overall survival (OS) from standard-of-care Stupp regimen while none of the patients...
Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a...
Plenary Oral Presentation at SNO will provide latest clinical trial results from the previously enrolled INB-200 studies of autologous gamma-delta T cells for newly diagnosed glioblastoma (GBM...
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0152 | 4.90480800258 | 0.3099 | 0.41 | 0.29 | 1545286 | 0.34620548 | CS |
4 | -0.0249 | -7.11428571429 | 0.35 | 0.41 | 0.29 | 638617 | 0.33683781 | CS |
12 | 0.0051 | 1.59375 | 0.32 | 0.5566 | 0.217 | 1212006 | 0.382373 | CS |
26 | -1.0749 | -76.7785714286 | 1.4 | 1.74 | 0.217 | 799136 | 0.52772485 | CS |
52 | -0.6749 | -67.49 | 1 | 2.48 | 0.217 | 649683 | 0.86258054 | CS |
156 | -6.7649 | -95.4146685472 | 7.09 | 7.18 | 0.217 | 681584 | 2.07562611 | CS |
260 | -9.6749 | -96.749 | 10 | 10.319 | 0.217 | 612695 | 2.12994484 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.